FDA Suspends Gene Therapy Study
Posted on: Thursday, 26 July 2007, 18:17 CDT
WASHINGTON - The government has suspended a Seattle company's gene therapy study - and is reviewing the safety of 28 others around the country - after learning that a patient died this week.
The Food and Drug Administration didn't reveal the cause of death, or any details about the patient, who had enrolled in a study of gene therapy for advanced arthritis.
But it marks the third blow since 1999 to the field of gene therapy, as scientists struggle to determine if the viruses they use to deliver new genes may themselves cause serious trouble.
Source: Associated Press/AP Online
Related Articles
- University of Florida; Enzyme protects cells during gene therapy
- Oncology; E1A gene therapy represents a new approach for treating Ewing sarcoma
- M.D. Anderson Cancer Center; E1A gene therapy represents a new approach for treating Ewing sarcoma
- Gene Therapy Could Lead to 'Super Athletes'
- Pulmonary Medicine; The additive effects of TRAIL and p53 gene therapy diminish cancer cell growth
- Seoul National University; The additive effects of TRAIL and p53 gene therapy diminish cancer cell growth
- Primer on Medical Genomics Part X: Gene therapy
- Parkinson's Gene Therapy Study Begins
- Benefits of some gene therapy may not outweigh its dangers
- Gene Therapy Problem Pinpointed
Rating: 2.9 / 5 (15 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds